| Stage | SOLS | % of rev | OLN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $1.7B | 100.00% | OLN ×1.52 |
| Gross profit | $370M | 32.23% | $173M | 9.88% | SOLS +22.3pp |
| Operating income | $197M | 17.16% | $59M | 3.39% | SOLS +13.8pp |
| Pre-tax income | $176M | 15.33% | $17M | 0.98% | SOLS +14.4pp |
| Net income | $134M | 11.67% | $14M | 0.82% | SOLS +10.8pp |
| Stage | SOLS | OLN | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $1.7B100.00% | OLN ×1.52 |
| Gross profit | 32.23%$370M | 9.88%$173M | SOLS +22.3pp |
| Operating income | 17.16%$197M | 3.39%$59M | SOLS +13.8pp |
| Pre-tax income | 15.33%$176M | 0.98%$17M | SOLS +14.4pp |
| Net income |
| 11.67%$134M |
| 0.82%$14M |
| SOLS +10.8pp |
No shared counterparties.